Skip to main content
OpenTrials
Completed

NCT Number: NCT05684471

SFIB vs Anterior QLB in Total Hip Arthroplasty

Quadratus lumborum block (QLB) is a facial plane block defined to provide analgesia from T7-L3 dermatomes. There are articles reporting that it is an effective analgesic method in hip surgeries. Suprainguinal fascia iliaca block (SIFIB) also blocks components of the lumbar plexus and provides effective analgesia in hip surgeries. The investigators aim to compare the effectiveness of QLB and SIFIB in patients undergoing primary total hip arthroplasty (THA).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Samsun University

Samsun, 55090, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • American Society of Anesthesiologists (ASA) classification I-II-III
  • Scheduled for total hip artroplasty surgery under spinal anesthesia

Exclusion criteria

  • Patients who did not want to participate in the study
  • Patients with cognitive dysfunction who cannot evaluate the NRS score and cannot use PCA
  • Known local anesthetics and opioid allergy,
  • Pregnancy or lactation
  • Patients with a contraindication to spinal and regional anesthesia
  • Presence of multiple fractures

Treatment and study plan

Ultrasound Guided Suprainguinal Fascia iliaca Block

Procedure

Patients in this group will be administered SFIB with 50 mL of local anesthetic solution (Bupivacaine %0.25) under ultrasound guidance after the surgery is completed.

Ultrasound Guided Anterior Quadratus Lumborum Block

Procedure

Patients in this group will be administered anterior QLB with 40 mL of local anesthetic (Bupivacaine %0.25) under ultrasound guidance after the surgery is completed.

Primary outcomes

  1. Cumulative opioid comsumption

    Time frame: up to 24 hour

    Morphine consumptions for both group will be recorded

Secondary outcomes

  1. Numeric rating scale for postoperative pain intensity

    Time frame: up to 24 hours

    Changes in Numeric Rating Scale (NRS) at rest and on movement will be recorded at intervals. (3-6-12-18-24th hour) NRS is a unidimensional measure of pain intensity in adults. The NRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of his/her pain. The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").

  2. Quality of Recovery (QoR-15)

    Time frame: at 24th hour

    The impact of surgical and anesthetic interventions on perioperative quality of life and ability to resume routine life activities will be assessed using the Quality of Recovery (QoR) tool. The QoR-15 scale is a patient-based outcome measure in the form of a 15-item validated questionnaire.

  3. Presence of quadriceps motor block (defined as paralysis or paresis).

    Time frame: up to 24 hours

    Quadriceps motor function will be tested with the patient supine and with the hip and knee flexed at 45º and 90º, respectively. The subject will be asked to extend the knee first against gravity and then against resistance. Quadriceps strength will be graded according to a 3-point scale: normal strength = 0 point (extension against resistance); paresis = 1 point (extension against gravity but not against resistance); and paralysis = 2 points (no extension).

Sponsors and collaborators

Lead sponsor

Samsun University

Other

Registry information

Official study title

Comparison of the Efficiency of Ultrasound-Guided Suprainguinal Fascia Iliaca Block and Anterior Quadratus Lumborum Block in Patients Undergoing Total Hip Arthroplasty Under Spinal Anesthesia

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Jan 13, 2023
Registry last updated
May 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.